Skeletal muscle dysfunction caused by obesity is characterized
by the decline in mitochondrial content and function. 5-Heptadecylresorcinol
(AR-C17) is a specific bioactive component derived from whole wheat
and rye, which has been evidenced to improve obesity-associated skeletal
muscle dysregulation. However, the mechanism underlying its protective
activity requires further exploration. Herein, we found that AR-C17
(5, 10, and 20 μM) intervention reversed PA-induced (0.5 mM)
reduction in mitochondrial content, mitochondrial membrane potential,
and mitochondrial energy metabolism in C2C12 cells. Meanwhile, AR-C17
evidently alleviated PA-mediated myotube mitochondrial dysfunction
via elevating mitochondria autophagy flux and upregulating the expression
level of autophagy-related protein, while this effect was abolished
by an autophagy inhibitor (3-MA). Further analysis showed that SIRT3-FOXO3A-PINK-Parkin-mediated
mitophagy was involved in the modulation of myocyte mitochondrial
dysfunction by AR-C17. In addition, AR-C17 administration (30 and
150 mg/kg/day) significantly improved high-fat-diet-induced mitochondrial
dysregulation in mice skeletal muscle tissue via SIRT3-dependent mitophagy.
Our findings indicate that skeletal muscle cells are responsive to
AR-C17, which improves myogenesis and mitophagy in vitro and in vivo.